Airbus has found buyers for six A320neo aircraft originally intended for Malaysia’s AirAsia
Airbus, which invited tenders for six the jets in April after AirAsia had failed to take delivery, has been steadily increasing deliveries coordinated with airlines to reschedule deliveries or store jets.
Last month, AirAsia announced that it had reduced the number of jets it had been unable to deliver during the pandemic by ten units to 135 jets. The redeployment of AirAsia orders will further trim the surplus.
Airbus is seeing relatively strong demand for its A321neo jet and is sticking with plans to produce more single-aisle jets.
The A321neo's largest competitor is the Boeing 737 MAX, which would re-enter the market after a 20-month grounding in the wake of two crashes.
Dozens of canceled 737 MAX orders whose buyers canceled during the grounding Boeing are expected to be sold.
According to the UK-based consultancy IBA Group, the A321neo is trading around 5 percent below its value while the MAX is 10 percent.
All aircraft have lost some value during the pandemic.
But there are doubts if demand would remain for Airbus' larger A330neo, whose largest customer, AirAsia X, is seeking new funding to survive.
In April, AirAsia said it would stop taking deliveries of all Airbus jets this year and review remaining orders.
The Malaysian carrier was also drawn into an Airbus bribery case in a sports sponsorship deal before being cleared by local investigators, industry sources have said.
AirAsia co-founders denied any wrongdoing.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



